blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3380106

EP3380106 - PLATINUM ANTICANCER AGENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.07.2020
Database last updated on 26.07.2024
FormerRequest for examination was made
Status updated on  31.08.2018
FormerThe international publication has been made
Status updated on  02.06.2017
Most recent event   Tooltip10.07.2020Application deemed to be withdrawnpublished on 12.08.2020  [2020/33]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
For all designated states
Cornell University
Centre for Technology Licensing at
Cornell University (CTL)
395 Pine Tree Road Suite 310
Ithaca, NY 14850 / US
[2018/40]
Inventor(s)01 / GIACOMINI, Kathleen, M.
104 Randolph Rd
Ithaca NY 14850 / US
02 / MORE, Swati
104 Randolph Rd
Ithaca NY 14850 / US
03 / YEE, Sook, Wah
104 Randolph Rd
Ithaca NY 14850 / US
04 / GEIER, Ethan
104 Randolph Rd
Ithaca NY 14850 / US
05 / WILSON, Justin
104 Randolph Rd
Ithaca NY 14850 / US
 [2018/40]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2018/40]HGF Limited
1 City Walk
Leeds LS11 9DX / GB
Application number, filing date16869194.722.11.2016
[2018/40]
WO2016US63408
Priority number, dateUS201562259842P25.11.2015         Original published format: US 201562259842 P
[2018/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017091616
Date:01.06.2017
Language:EN
[2017/22]
Type: A1 Application with search report 
No.:EP3380106
Date:03.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 01.06.2017 takes the place of the publication of the European patent application.
[2018/40]
Search report(s)International search report - published on:US01.06.2017
(Supplementary) European search report - dispatched on:EP11.06.2019
ClassificationIPC:A61K33/24, C07F15/00, C07D487/04, A61P35/04
[2019/28]
CPC:
A61K33/243 (EP,US); C07F15/0093 (US); A61P35/04 (EP,US);
C07D487/04 (EP,US)
Former IPC [2018/40]A61K33/24
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/40]
TitleGerman:ANTIKREBSMITTEL AUF PLATINBASIS[2018/40]
English:PLATINUM ANTICANCER AGENTS[2018/40]
French:AGENTS ANTICANCÉREUX À BASE DE PLATINE[2018/40]
Entry into regional phase19.06.2018National basic fee paid 
19.06.2018Search fee paid 
19.06.2018Designation fee(s) paid 
19.06.2018Examination fee paid 
Examination procedure19.06.2018Examination requested  [2018/40]
19.06.2018Date on which the examining division has become responsible
16.01.2019Amendment by applicant (claims and/or description)
09.01.2020Application deemed to be withdrawn, date of legal effect  [2020/33]
28.02.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/33]
Fees paidRenewal fee
27.11.2018Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.11.201904   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]  - VITOLS K S ET AL, "Platinum-folate compounds: synthesis, properties and biological activity", ADVANCES IN ENZYME REGULATION, PERGAMON PRESS, OXFORD, GB, vol. 26, doi:10.1016/0065-2571(87)90004-5, ISSN 0065-2571, (19870101), pages 17 - 27, (19870101), XP023853086 [I] 1,2,4-6,9-15 * figure 3 *

DOI:   http://dx.doi.org/10.1016/0065-2571(87)90004-5
International search[A]US2011284799  (STOESSEL PHILIPP [DE], et al) [A] 1-25* entire document especially pg 53, top, compound 310 *;
 [A]US2014057869  (CHRISTIAN SAMUEL T [US]) [A] 1-25 * , entire document, especially: pg 15, Table B, third formula, methotrexate; pg 15, Table B, fifth formula, cisplatin; pg 10, Table A, aminopterin platinum coordination complexes; para [0024]; para [0059]; para [0086]; para [0123]. *;
 [A]  - VISTOLS et al., "Platinum-folate compounds: synthesis, properties and biological activity", Adv Enzyme Regul., (19870000), vol. 26, pages 17 - 27, XP023853086 [A] 1-25 * , entire document, especially: pg 17, para 3; pg 19, Fig 3, platinum tetrahydrofolate; pg 20, para 1. *

DOI:   http://dx.doi.org/10.1016/0065-2571(87)90004-5
 [A]  - PubChem, (20120819), Database accession no. 58517492, XP055386889 [A] 1-25 * , Fig. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.